M. Crane

发表

Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis

G. Illei, A. Steinberg, D. Boumpas, 2001, Annals of Internal Medicine.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

G. Illei, A. Steinberg, D. Parkin, 2002, Arthritis and rheumatism.

Human immunodeficiency virus infection and the liver.

S. Lewin, M. Crane, D. Iser, 2012, World journal of hepatology.

Clinic-Level Factors Associated With Retention in Care Among People Living With Human Immunodeficiency Virus in a Multisite US Cohort, 2010–2016

M. Mugavero, P. Rebeiro, E. Geng, 2020 .

IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis1

G. Illei, I. McInnes, C. Prussin, 2001, The Journal of Immunology.

Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy.

S. Lewin, K. Ruxrungtham, G. Dore, 2014, The Journal of infectious diseases.

HIV Infection and TLR Signalling in the Liver

S. Lewin, K. Visvanathan, M. Crane, 2012, Gastroenterology research and practice.

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection

S. Lewin, P. Revill, J. Torresi, 2020, PLoS pathogens.

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.

S. Lewin, K. Ruxrungtham, P. Price, 2009, The Journal of infectious diseases.

Hepatitis virus immune restoration disease of the liver

S. Lewin, G. Matthews, M. Crane, 2008, Current opinion in HIV and AIDS.

Coinfection of Hepatic Cell Lines with Human Immunodeficiency Virus and Hepatitis B Virus Leads to an Increase in Intracellular Hepatitis B Surface Antigen

Suha M. Saleh, S. Lewin, P. Revill, 2010, Journal of Virology.

Immunopathogenesis of HIV co-infections

Christina C. Chang, S. Lewin, A. Lloyd, 2014 .

HIV and co‐infections

Jingling Zhou, Christina C. Chang, S. Lewin, 2013, Immunological reviews.

HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment

S. Lewin, J. Sasadeusz, A. Avihingsanon, 2017, AIDS.

No Increase in Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Patients with HIV-1-HBV Coinfections following HBV-Active Highly Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, S. Sirivichayakul, 2010, Journal of Virology.

Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.

A. Wiznia, G. Lambert, M. Crane, 1996, JAMA.

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy

Wei Zhao, S. Lewin, P. Revill, 2022, EBioMedicine.

Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation.

H R Schumacher, G. Chrousos, H. Schumacher, 2000, The Journal of clinical endocrinology and metabolism.

Pro-fibrogenic role of alarmin high mobility group box 1 in HIV–hepatitis B virus coinfection

S. Lewin, M. Pinzani, M. Maini, 2022 .

Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders.

S. Lewin, D. McPhee, P. Gorry, 2010, Clinical immunology.

Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action

M. Crane, T. Gillis, N. Wei, 2017, Open access rheumatology : research and reviews.

Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B.

S. Lewin, N. Chuaypen, P. Tangkijvanich, 2019, Asian Pacific journal of allergy and immunology.

CXCL-10, Interleukin-12 and Interleukin-21 are not Immunological Predictors of Hbeag Seroconversion in HIV-1–HBV Coinfection following HBV-Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, J. Sasadeusz, 2014, Antiviral therapy.

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells

K. Subbarao, J. Crawford, E. B. Clemens, 2023, Cell Reports Medicine.

AB0502 H.P. Acthar® Gel (Repository Corticotropin Injection) as Adjunctive Therapy in Patients with Rheumatoid Arthritis who Have Failed at Least Three Biologic Therapies with Different Modes of Action

M. Crane, N. Wei, C. Hinkle, 2015 .

Genotypic resistance testing in HIV-infected pregnant women in an urban setting

K. Monaghan, M. Crane, J. McGowan, 2004 .

Genotypic resistance testing in HIV-infected pregnant women in an urban setting

K. Monaghan, M. Crane, J. McGowan, 2004, International journal of STD & AIDS.

LPS , immune activation and liver abnormalities in HIV-HBV co-infected individuals on HBV-active combination antiretroviral therapy

Doré, Pushparaj, S. Lewin, 2014 .

Editorial: HIV and lipopolysaccharide: double trouble in the liver

S. Lewin, M. Crane, 2017, Journal of Leukocyte Biology.

Pro-fibrogenic role of alarmin high mobility group box 1 in HIV–hepatitis B virus coinfection

S. Lewin, M. Pinzani, M. Maini, 2022, AIDS.

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy

A. Avihingsanon, M. Crane, J. Audsley, 2024, EBioMedicine.